Akumin Inc 's ability to collect accounts receivable sequentially worsen to 6.38, indicating more challenging environment then in the second quarter 2023, but still, it is a far cry from any concerns. Akumin Inc 's Accounts Receivable average collection period in the Sep 30 2023 quarter, has increased to 57 days, from 56 days, in the Jun 30 2023 quarter.

If we take a look into Healthcare sector 323 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2023 from 2182 to 2424.

What is Receivable Turnover Ratio?
What is Akumin Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AKU Receivables Turnover Ratio	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter
Y / Y Receivable Change	5.09 %	-8.21 %	-9.32 %	-6.06 %	-16.89 %
Y / Y Revenue Change	-3.21 %	-3.79 %	0.71 %	2.89 %	72.5 %
Receivable Turnover Ratio (TTM)	6.38	6.51	6.43	6.26	6.12
AKU's Total Ranking	# 2424	# 2182	# 2163	# 2161	# 0
Accounts Receivable average collection period days	57	56	57	58	60
Seq. Receivable Change	1.99 %	0.95 %	0.46 %	1.59 %	-10.92 %
Seq. Revenue Change	-2.28 %	-1.47 %	1.6 %	-1.06 %	-2.87 %

Receivable Turnover Company Ranking
Within:	No.
Medical Laboratories Industry	# 20
Healthcare Sector	# 324
Overall Market	# 2424

Receivable Turnover Ratio Statistics
High	Average	Low
0.44	0.42	0.4
(Sep 30 2023)		(Sep 30 2022)

AKU Company Profile • Back to AKU Efficiency Comparisons • Compare AKU Receivables Turnover Ratio to its Competitors

Financial Statements
Akumin Inc 's Accounts Receivable	$ 118 Millions	Visit AKU's Balance sheet
Akumin Inc 's Sales TTM	$ 738 Millions	Visit AKU's Income Statement
Sources of AKU's Revenues		Visit AKU's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
AKU's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
AKU's Growth Rates	AKU's Roa	AKU's Inventory Turnover Ratio	AKU's Dividend Comparisons
AKU's Profitability Ratios	AKU's Roi	AKU's Asset Turnover Ratio	AKU's Dividend Growth
AKU's Valuation Ratios	AKU's Roe	AKU's Financial Strength Ratios	AKU's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2023	Receivable at quarter ending Sep 30 2023
Neptune Wellness Solutions Inc	16.05	$ 43.724 Millions	$ 2.724 Millions
Opus Genetics Inc	15.89	$ 57.208 Millions	$ 3.600 Millions
Scienture Holdings Inc	15.48	$ 9.101 Millions	$ 0.588 Millions
Chemed Corporation	15.30	$ 2,225.159 Millions	$ 145.392 Millions
Vystar Corporation	15.28	$ 0.417 Millions	$ 0.027 Millions
Patterson Companies Inc	14.56	$ 6,550.083 Millions	$ 449.864 Millions
Gyre Therapeutics Inc	14.41	$ 79.758 Millions	$ 5.534 Millions
Talkspace Inc	14.24	$ 137.071 Millions	$ 9.623 Millions
Comera Life Sciences Holdings Inc	14.07	$ 1.000 Millions	$ 0.071 Millions
Lifeloc Technologies Inc	14.00	$ 9.250 Millions	$ 0.661 Millions
Nexalin Technology Inc	13.80	$ 0.129 Millions	$ 0.009 Millions
Corcept Therapeutics Inc	13.76	$ 450.026 Millions	$ 32.698 Millions
Escalon Medical Corp	13.72	$ 12.520 Millions	$ 0.912 Millions
Protalix Biotherapeutics inc	13.48	$ 63.625 Millions	$ 4.719 Millions
Exact Sciences Corporation	13.42	$ 2,413.259 Millions	$ 179.784 Millions
Dmk Pharmaceuticals Corporation	13.38	$ 3.525 Millions	$ 0.264 Millions
Arrowhead Pharmaceuticals Inc	13.36	$ 240.735 Millions	$ 18.023 Millions
Petvivo Holdings Inc	13.14	$ 0.960 Millions	$ 0.073 Millions
Icu Medical Inc	13.12	$ 2,247.910 Millions	$ 171.300 Millions
Milestone Scientific Inc	13.11	$ 9.788 Millions	$ 0.747 Millions
Sunlink Health Systems Inc	12.92	$ 45.936 Millions	$ 3.556 Millions
Arbutus Biopharma Corp	12.89	$ 22.241 Millions	$ 1.725 Millions
Yubo International Biotech Limited	12.56	$ 0.653 Millions	$ 0.052 Millions
Utah Medical Products Inc	12.49	$ 51.339 Millions	$ 4.112 Millions
Ideaya Biosciences Inc	12.46	$ 23.484 Millions	$ 1.886 Millions
Nutriband Inc	12.45	$ 2.088 Millions	$ 0.168 Millions
Precipio inc	12.45	$ 13.259 Millions	$ 1.065 Millions
Revance Therapeutics Inc	12.38	$ 214.162 Millions	$ 17.292 Millions
Equillium Inc	12.38	$ 42.632 Millions	$ 3.444 Millions
Amylyx Pharmaceuticals Inc	12.30	$ 294.222 Millions	$ 23.922 Millions

Date modified: 2026-09-18T14:07:35+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.